Sanyuan Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 57.4819 million yuan, an increase of 10.73%

According to the Zhitong Finance APP, Sanyuan Biotechnology released its semi-annual report for 2025, showing an operating income of 318 million yuan, a year-on-year decrease of 15.62%. The net profit attributable to shareholders of the listed company was 57.4819 million yuan, a year-on-year increase of 10.73%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 48.7566 million yuan, a year-on-year decrease of 4.70%. The basic earnings per share were 0.29 yuan